Premium Information is available for this item - Upgrade for $1 a day

6505-00-221-3433

Usp Dapsone Tablets

6505002213433 002213433 AVL0SULF0NE 46-0450-81

INC: 28173 Dapsone Tablets

6505-00-221-3433 DAPSONE TABLETS,USP 6505002213433 002213433

Managed by United States
NSN Created on 11 May 1973
Data Last Changed
November 2023
NATO Update Count
7
NATO Data Quality
6505-00-221-3433 DAPSONE TABLETS,USP 6505002213433 002213433 1/1
NSN 6505-00-221-3433 (Generic Image) 1/1

6505-00-221-3433 Stock and Availability Marketplace 6505-00-221-3433

Need Help?
Request a Quotation from participating marketplace vendors
eBay Updated Every Day
6505-00-221-3433 RQST NE eBay
eBay Updated Every Day
6505-00-221-3433 RQST eBay
Amazon Updated Every Day
6505-00-221-3433 RQST NE Amazon

6505-00-221-3433 Related Documents Related Documents 6505-00-221-3433 5+ Documents (More...)

AVL0SULF0NE 46-0450-81 Managed by United States NSN Created on 11 May 1973 Data Last Changed November
RQST NE Updated Every Day 6505-00-221-3433 RQST Updated Every Day 6505-00-221-3433 RQST NE Related Documents
6505-00-221-3433 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-221-3433
fsg-65/fsc-6505/br 6505-19-001-2537 Dapsone Tablets 6505190012537 190012537 Numbers Related to 6505-00-221-3433
002213433 Dapsone Tablets 6505190012537190012537 6505/uk 6505-99-211-3116 https//www.nsnlookup.com /
fsg-65/fsc-6505/us 6505-00-221-3433 Usp Dapsone Tablets 6505002213433 002213433 Usp Dapsone Tablets 6505992113116
6505/uk 6505-99-211-3116 Usp Dapsone Tablets 6505992113116 992113116 Tablets 6505992113116992113116 002213433
fsg-65/fsc-6505/br 6505-19-001-2537 Dapsone Tablets 6505190012537190012537 Numbers Related to 6505-00-221-3433
6505190012537190012537 001-2537 6505-19-001-2537 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-221-3433
NSN Created on 4 Aug by United States NSN Created on 4 Aug Dapsone Tablets 6505992113116 992113116 002213433
Usp Dapsone Tablets 6505002213433 002213433 3433 Usp Dapsone https//www.nsnlookup.com /fsg-65/fsc
www.nsnlookup.com /fsg-65/fsc-6505/uk 6505-99-211-3116 Usp Dapsone Tablets 6505992113116 992113116 002213433
6505190012537190012537 www.nsnlookup.com Documents ( More... ) https//www.nsnlookup.com https//www.nsnlookup.com 002213433
6505-01- https 6505-00-880-9257 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-221-3433 Usp Dapsone
Tablets 6505002213433 002213433 Tablets 6505002213433002213433 Usp Dapsone Tablets https//www.nsnlookup.com

6505-00-221-3433 Demil Restrictions 6505-00-221-3433

DEMIL: A | DEMILI: 1 | CRITICALITY: X | HMIC: P | PMIC: U | EDC: | ADPEC:

6505-00-221-3433 is a Usp Dapsone Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.

6505-00-221-3433 End Users End Users 6505-00-221-3433

NASA (G57V)
Effective Date:
1 Apr 1991

6505-00-221-3433 Manufacturers Approved Sources 6505-00-221-3433

6505-00-221-3433 Technical Data Datasheet 6505-00-221-3433

Characteristic
Specifications
Active Medicament Medicinal Strength [AKJA]
100.000 Milligrams Dapsone Active Ingredient
Administration [CSGS]
Oral
Primary Container Type [CQCT]
Bottle
Primary Container Content Quantity [CRLK]
100.000 Tablets

6505-00-221-3433 Similar Items Similar Supply Items to 6505-00-221-3433

6505-00-221-3433 Freight Data Freight Information 6505-00-221-3433

6505-00-221-3433 has freight characteristics.. 6505-00-221-3433 has a variance between NMFC and UFC when transported by rail and the description should be consulted.